Device manufacturer, as written on reports
Becton Dickinson: medical device reports filed with FDA
44,307 reports name it as the manufacturer of the device involved, 1992–2026.
- 44,307
- reports naming it as manufacturer
- 0.2% of all MAUDE reports
- 5,236
- reports, 12 months to August 2026
- 4,235 in the 12 months before
- 88.2%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
44,307 medical device reports received by FDA give Becton Dickinson as the manufacturer of the device involved, 0.2% of the MAUDE database, from January 1992 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
5,236 reports arrived in the 12 months to August 2026, up 24% from 4,235 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.2%), injury (7.8%) and other (3.7%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Plate Columbia Ag 5% Sb 90mm 20 | Culture media, enriched | 2,496 | 2,496 | 0% |
| Unspecified Bd Pen Needle | Needle, hypodermic, single lumen | 1,794 | 0 | 0.1% |
| Bd Paradigm Link Blood Glucose Monitor | System, test, blood glucose, over the counter | 1,166 | 0 | 0.1% |
| Unspecified Bd Syringe | Syringe, piston | 852 | 0 | 0.1% |
| BD BBL Columbia Agar with 5% Sheep Blood | Lectins and protectins | 705 | 709 | 0% |
| BD Vacutainer Safety-Lok Blood Collection Set | Tubes, vials, systems, serum separators, blood collection | 614 | 144 | 0% |
| Syringe 50ml Ll | Syringe, piston | 440 | 23 | 0% |
| BD Vacutainer Buffered Sodium Citrate (9NC) Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 436 | 211 | 0% |
| Bd Plastipak Concentric Luer Lock Syringe | Syringe, piston | 408 | 0 | 0.2% |
| BD Vacutainer EDTA 2K | Tubes, vials, systems, serum separators, blood collection | 309 | 53 | 0.1% |
| Unspecified BD Infusion Set | Set, administration, intravascular | 305 | 484 | 0.2% |
| Bd Logic Blood Glucose Monitor | System, test, blood glucose, over the counter | 301 | 0 | 0% |
| Unspecified Bd Needle | Needle, hypodermic, single lumen | 301 | 0 | 0% |
| Unspecified Bd Lihep No Gel Collection Tube | Tubes, vials, systems, serum separators, blood collection | 277 | 0 | 0% |
| BD Syringe | Syringe, piston | 249 | 117 | 0.4% |
| Bd Vacutainer Pst Gel And Lithium Heparinn Lh Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 246 | 2 | 0% |
| Unspecified Bd Introsyte Introducer | Introducer, catheter | 219 | 0 | 0% |
| BD Vacutainer K2 EDTA (K2E) 7.2mg Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 203 | 103 | 0% |
| Unspecified Bd Catheter | Catheter, intravascular, therapeutic, short-term less than 30 days | 194 | 0 | 0% |
| BD Vacutainer Rapid Serum Tube (RST) Blood Collection Tubes Thrombin | Tubes, vials, systems, serum separators, blood collection | 185 | 13 | 0% |
| Bd Plastipak Syringe | Syringe, piston | 181 | 25 | 0% |
| Needle Filter Blunt Fill 18x1-1/2 | Needle, aspiration and injection, disposable | 161 | 49 | 0% |
| Bd Plastipak 50ml Concentric Luer Lock Syringe | Syringe, piston | 158 | 0 | 0.5% |
| Syringe 50ml Ll Tip 1ml | Syringe, piston | 156 | 10 | 0% |
| Bd Microtainer Contact-Activated Lancet | Single use only blood lancet with an integral sharps injury prevention feature | 152 | 10 | 0% |
| Needle 18x1-1/2 Blunt Fill | Needle, aspiration and injection, disposable | 144 | 18 | 0% |
| Bd Plastipak Luer-Lok Syringe | Syringe, piston | 143 | 0 | 0% |
| Bd Vacutainer K2 Edta K2e Plus Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 143 | 15 | 0% |
| Bd Plastipak Syringes | Syringe, piston | 136 | 0 | 0.5% |
| BD Vacutainer K2 EDTA (K2E) 5.4mg Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 133 | 173 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| FMF | Syringe, piston | 9,574 | 21.6% |
| JKA | Tubes, vials, systems, serum separators, blood collection | 7,766 | 17.5% |
| FMI | Needle, hypodermic, single lumen | 7,446 | 16.8% |
| FOZ | Catheter, intravascular, therapeutic, short-term less than 30 days | 3,435 | 7.8% |
| ONB | Closed antineoplastic and hazardous drug reconstitution and transfer system | 2,817 | 6.4% |
| FPA | Set, administration, intravascular | 2,649 | 6% |
| KZI | Culture media, enriched | 2,580 | 5.8% |
| NBW | System, test, blood glucose, over the counter | 1,729 | 3.9% |
| KSI | Lectins and protectins | 700 | 1.6% |
| GAA | Needle, aspiration and injection, disposable | 402 | 0.9% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Becton Dickinson reports
How many FDA device reports name Becton Dickinson as manufacturer?
44,307 reports through August 2026, 5,236 of them in the latest 12 months.
Which of its brands appear most often?
Plate Columbia Ag 5% Sb 90mm 20 (2,496), Unspecified Bd Pen Needle (1,794), Bd Paradigm Link Blood Glucose Monitor (1,166), Unspecified Bd Syringe (852) and BD BBL Columbia Agar with 5% Sheep Blood (705).
Which device types does it report on?
syringe, piston (21.6%), tubes, vials, systems, serum separators, blood collection (17.5%), needle, hypodermic, single lumen (16.8%) and catheter, intravascular, therapeutic, short-term less than 30 days (7.8%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.